FORESIGHT ACQUISITION CORP-A (FORE) Fundamental Analysis & Valuation

NASDAQ:FORE

Current stock price

9.48
+0.46 (+5.04%)
Last:

This FORE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. FORE Profitability Analysis

1.1 Basic Checks

  • FORE had negative earnings in the past year.
FORE Yearly Net Income VS EBIT VS OCF VS FCFFORE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020

1.2 Ratios

Industry RankSector Rank
ROA 0%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FORE Yearly ROA, ROE, ROICFORE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for FORE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FORE Yearly Profit, Operating, Gross MarginsFORE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020

6

2. FORE Health Analysis

2.1 Basic Checks

FORE Yearly Shares OutstandingFORE Yearly Shares OutstandingYearly Shares Outstanding 2020 10M 20M 30M
FORE Yearly Total Debt VS Total AssetsFORE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 100K 200K 300K

2.2 Solvency

  • An Altman-Z score of 14.02 indicates that FORE is not in any danger for bankruptcy at the moment.
  • There is no outstanding debt for FORE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 14.02
ROIC/WACCN/A
WACCN/A
FORE Yearly LT Debt VS Equity VS FCFFORE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 5K 10K 15K

2.3 Liquidity

  • A Current Ratio of 4.39 indicates that FORE has no problem at all paying its short term obligations.
  • FORE has a Quick Ratio of 4.39. This indicates that FORE is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 4.39
Quick Ratio 4.39
FORE Yearly Current Assets VS Current LiabilitesFORE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 100K 200K 300K

0

3. FORE Growth Analysis

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. FORE Valuation Analysis

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
FORE Price Earnings VS Forward Price EarningsFORE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FORE Per share dataFORE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. FORE Dividend Analysis

5.1 Amount

  • No dividends for FORE!.
Industry RankSector Rank
Dividend Yield N/A

FORE Fundamentals: All Metrics, Ratios and Statistics

FORESIGHT ACQUISITION CORP-A

NASDAQ:FORE (12/3/2021, 8:59:24 PM)

9.48

+0.46 (+5.04%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners62.26%
Inst Owner ChangeN/A
Ins Owners19.34%
Ins Owner Change0%
Market Cap372.67M
Revenue(TTM)N/A
Net Income(TTM)N/A
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.24
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS7.66
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 0%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score0
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.39
Quick Ratio 4.39
Altman-Z 14.02
F-Score0
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

FORESIGHT ACQUISITION CORP-A / FORE Fundamental Analysis FAQ

What is the fundamental rating for FORE stock?

ChartMill assigns a fundamental rating of 1 / 10 to FORE.


What is the valuation status of FORESIGHT ACQUISITION CORP-A (FORE) stock?

ChartMill assigns a valuation rating of 1 / 10 to FORESIGHT ACQUISITION CORP-A (FORE). This can be considered as Overvalued.


How profitable is FORESIGHT ACQUISITION CORP-A (FORE) stock?

FORESIGHT ACQUISITION CORP-A (FORE) has a profitability rating of 0 / 10.


Can you provide the financial health for FORE stock?

The financial health rating of FORESIGHT ACQUISITION CORP-A (FORE) is 3 / 10.